Biotechnology

Frost & Sullivan grants the Global Cognitive Impairment Digital Therapy Innovation Award to BRAINAU

SHANGHAI, Sept. 19, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held inShanghai from August 27 to 30, 2024 , co-hosted by LeadLeo. Based on research and analysis of the global...

2024-09-19 21:48 2900

Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Sept. 19, 2024 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, tod...

2024-09-19 17:28 4285

Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture

Amid rising agricultural complexity and the push for sustainability, genomics is at the forefront of innovation in breeding practices. SINGAPORE, Sept. 19, 2024 /PRNewswire/ -- Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomic...

2024-09-19 14:00 11637

Transcenta Updates Encouraging Efficacy Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ESMO 2024

Updated results with longer follow-up reveal confirmed ORR of 68% and median PFS of 14.2 months in patients with CLDN18.2 high or medium expression, known PD-L1 CPS (n=66). PRINCETON, N.J. and SUZHOU, China, Sept. 19, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), ...

2024-09-19 08:00 6189

Watson-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively

SINGAPORE, Sept. 19, 2024 /PRNewswire/ -- Watson-Marlow Fluid Technology Solutions (WMFTS), a world leader in manufacturing peristaltic pump and associated fluid path technologies for process industries and life sciences, has announced the launch ofQdos™ H-FLO

2024-09-19 08:00 13881

Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen's Lawsuit

IRVINE, Calif., Sept. 18, 2024 /PRNewswire/ -- Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH onAugust 20, 2024, at the US District Court for the Central District ofCalifornia regarding its MAGicBead cfDN...

2024-09-18 22:00 1976

Frost & Sullivan grants the Global Medical Imaging Foundation Model Innovation Award to Hangzhou Diagens Biotechnology Co.,Ltd.

SHANGHAI, Sept. 18, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held inShanghai from August 27 to 30, 2024 , co-hosted by LeadLeo. Based on the research and analysis of the gl...

2024-09-18 16:16 2239

Clarivate Announces 15th Annual Pharmavision India Conference Agenda

Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event LONDON, Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 15th annua...

2024-09-18 15:00 2684

BioDuro-Sundia Appoints Dr. Armin Spura as New Chief Executive Officer

SHANGHAI, Sept. 18, 2024 /PRNewswire/ -- BioDuro-Sundia, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to announce the appointment of Dr.Armin Spura as its new Chief Executive Officer. Dr. Spura brings over two decades of experience in the life scien...

2024-09-18 08:30 3368

Alphamab Oncology Presented the Latest Clinical Data from Two Studies on Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024

SUZHOU, China, Sept. 16, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from two studies on anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 were presented at the 2024 European Society for Medical Oncology Congress (ESMO Congress 202...

2024-09-16 13:03 2983

Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)

* In Phase Ia clinical study, GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects, maintaining a stable glucose-lowering effect for up to one week with a single administration. * In Phase Ib clinical study, patients with Type 2 diabetes mellitus (T2DM) receiving s...

2024-09-14 19:00 5582

Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation

ROCKVILLE, Md. and SUZHOU, China, Sept. 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released t...

2024-09-14 08:18 5682

BeiGene Singapore Raises Awareness for World Lymphoma Awareness Day 2024: It's Time for Honest Talk

SINGAPORE, Sept. 13, 2024 /PRNewswire/ -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, is proud to join the global community in raising awareness about lymphoma on World Lymphoma Awareness Day (WLAD). Lymphoma, a type of blood cancer affecting millions of peo...

2024-09-13 09:00 3611

Aurora Biosynthetics Launches to Revolutionize RNA Therapeutics Manufacturing

SYDNEY, Sept. 13, 2024 /PRNewswire/ -- Aurora Biosynthetics, a pioneering advanced RNA therapeutics manufacturing company, announced its official launch. This heralds a new era in RNA therapeutics manufacturing across theAsia-Pacific region. Aurora Biosynthetics is poised to meet the surging dema...

2024-09-13 04:00 3352

Genea Biomedx solidifies its exclusive partnership in Australia with Genea Fertility

SYDNEY, Sept. 12, 2024 /PRNewswire/ -- Genea Biomedx, which was once part of Genea Fertility, joined the Basecare Medical group in 2023 with the aim of distributing Basecare's assisted reproductive technology internationally. ...

2024-09-12 17:44 2901

BMC at ERS 2024: Exploring the Future of Sleep and Respiratory Health

BEIJING, Sept. 12, 2024 /PRNewswire/ -- From September 7th to September 11th, the European Respiratory Society (ERS) Congress successfully concluded in Vienna, Austria. The ERS Congress is an annual event that brings together the world's respiratory experts to showcase the latest advances in respi...

2024-09-12 13:47 1747

'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology

MELBOURNE, Australia, Sept. 11, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that primary results from its Phase III ZIRCON[1] trial have been published in The Lancet Oncology, reporting that Telix's first-in-class investigational PET[2] agent,...

2024-09-11 06:46 2464

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months BOSTON and ROLLE, Switzerland, Sept. 10, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medic...

2024-09-10 22:50 2481

LifeSpan Vision Ventures Invests in Remedium Bio

NORWALK, Conn., Sept. 10, 2024 /PRNewswire/ -- LifeSpan Vision Ventures today announced that it has closed an investment in Remedium Bio.   - The biotechnology company is developing a first-in-class adjus...

2024-09-10 22:17 2032

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024

GAITHERSBURG, Md., Sept. 10, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for ...

2024-09-10 20:00 4012
1 ... 54555657585960 ... 185